Hong Kong Pharma Digital Technology Co. Ltd. | Micro-cap | Healthcare
$0.98
-2.97%
| Hong Kong Pharma Stock Comparison:
Hong Kong Pharma vs Walgreens BootsHong Kong Pharma vs High TideHong Kong Pharma vs PetMed ExpressHong Kong Pharma vs Wellgistics HealthHong Kong Pharma vs Scienture HoldingsHong Kong Pharma vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

No financial overview data available.

Hong Kong Pharma Income Statement From 2023 to 2024

Metric20242023
Revenue i16.7M12.6M
Cost of Goods Sold i13.1M9.8M
Gross Profit i3.6M2.7M
Gross Margin % i21.3%21.8%
Operating Expenses
Research & Development i--
Selling, General & Administrative i1.9M1.8M
Other Operating Expenses i-4.0K-96.2K
Total Operating Expenses i1.9M1.7M
Operating Income i1.7M1.1M
Operating Margin % i10.0%8.6%
Non-Operating Items
Interest Income i474219
Interest Expense i82.8K23.2K
Other Non-Operating Income-65.0K-33.3K
Pre-tax Income i1.5M1.0M
Income Tax i196.3K22.6K
Effective Tax Rate % i12.9%2.2%
Net Income i1.3M998.2K
Net Margin % i8.0%7.9%
Key Metrics
EBITDA i2.6M1.8M
EPS (Basic) i-$0.09
EPS (Diluted) i-$0.09
Basic Shares Outstanding i-11000000
Diluted Shares Outstanding i-11000000

Income Statement Trend

Hong Kong Pharma Balance Sheet From 2023 to 2024

Metric20242023
Assets
Current Assets
Cash & Equivalents i619.6K524.6K
Short-term Investments i--
Accounts Receivable i3.7M1.6M
Inventory i933.3K190.9K
Other Current Assets--
Total Current Assets i7.8M2.7M
Non-Current Assets
Property, Plant & Equipment i855.1K599.7K
Goodwill i31.8K4.0K
Intangible Assets i31.8K4.0K
Long-term Investments--
Other Non-Current Assets--
Total Non-Current Assets i865.5K658.3K
Total Assets i8.7M3.4M
Liabilities
Current Liabilities
Accounts Payable i1.3M1.4M
Short-term Debt i849.7K419.6K
Current Portion of Long-term Debt--
Other Current Liabilities--
Total Current Liabilities i3.2M2.6M
Non-Current Liabilities
Long-term Debt i1.2M271.5K
Deferred Tax Liabilities i--
Other Non-Current Liabilities--
Total Non-Current Liabilities i1.2M271.5K
Total Liabilities i4.4M2.8M
Equity
Common Stock i10.0K6.8K
Retained Earnings i1.5M201.4K
Treasury Stock i--
Other Equity--
Total Shareholders Equity i4.3M585.2K
Key Metrics
Total Debt i2.1M691.1K
Working Capital i4.6M198.4K

Balance Sheet Composition

Hong Kong Pharma Cash Flow Statement From 2023 to 2024

Metric20242023
Operating Activities
Net Income i1.3M998.2K
Depreciation & Amortization i925.6K714.6K
Stock-Based Compensation i--
Working Capital Changes i-2.8M172.1K
Operating Cash Flow i-589.9K1.9M
Investing Activities
Capital Expenditures i-19.5K-114.6K
Acquisitions i--
Investment Purchases i--
Investment Sales i--
Investing Cash Flow i-5.5K-129.0K
Financing Activities
Share Repurchases i--
Dividends Paid i--
Debt Issuance i2.1M189.2K
Debt Repayment i-1.8M-1.3M
Financing Cash Flow i537.3K-1.2M
Free Cash Flow i-482.3K1.6M
Net Change in Cash i-58.1K600.2K

Cash Flow Trend

Hong Kong Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 6.26
Price to Book 2.31
Price to Sales 0.57

Profitability Ratios

Profit Margin -0.13%
Operating Margin -9.05%
Return on Equity -0.59%
Return on Assets 1.32%

Financial Health

Current Ratio 2.99
Debt to Equity 47.60

Per Share Data

EPS (TTM) $0.00
Book Value per Share $0.45
Revenue per Share $1.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
hkpd11.5M6.262.31-0.59%-0.13%47.60
Walgreens Boots 10.5B27.101.46-69.58%-4.07%409.88
High Tide 248.5M-61.201.77-6.69%-1.76%44.69
PetMed Express 62.6M303.000.650.36%0.15%1.15
Wellgistics Health 56.8M-5.4710.27-2,124.65%-135.22%571.67
Scienture Holdings 19.5M2.370.25-54.26%4.39%5.30

Financial data is updated regularly. All figures are in the company's reporting currency.